Biosig Technologies Inc., of Westport, Conn., appointed Michael Schmertzler to the board of its majority-owned subsidiary Viralclear Pharmaceuticals Inc.

Oligomerix Inc., of New York, appointed Robert Foerster chief financial officer.

TG Therapeutics Inc., of New York, appointed Owen A. O’Connor chief scientific officer. 

No Comments